×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| MEDICO REMEDIES LIMITED | 415.96 | 43.41 | 413.03 | 0.52 | 335.0 | 33.2 |
| Trident Lifeline Limited | NA | NA | NA | NA | 314 | 22.0 |
| KIMIA BIOSCIENCES LIMITED | 386.86 | 19.92 | 382.44 | 0.42 | 297 | 30.9 |
MEDICO REMEDIES LIMITED, with Security Code 540937, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 38.8 | 28.0 | 31.5 | 42.4 | 29.8 | 41.3 | 30.8 | 39.3 | 39.5 | 41.3 |
| Expenses | 35.5 | 24.8 | 29.0 | 39.3 | 27.0 | 36.7 | 28.0 | 36.9 | 36.4 | 34.5 |
| Operating Profit | 3.4 | 3.2 | 2.5 | 3.1 | 2.7 | 4.6 | 2.8 | 2.4 | 3.1 | 6.8 |
| OPM % | 8.72% | 11.3% | 7.8% | 7.26% | 9.18% | 11.24% | 9.13% | 6.13% | 7.88% | 16.37% |
| Other Income | 0.9 | 0.0 | 0.3 | 1.0 | 0.3 | 0.6 | 0.3 | 0.7 | 1.4 | 0.3 |
| Interest | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.5 |
| Depreciation | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 |
| Profit before tax | 3.3 | 2.3 | 1.9 | 3.1 | 2.1 | 4.2 | 2.2 | 2.1 | 3.5 | 5.8 |
| Tax % | -32.2% | -22.3% | -29.9% | -22.8% | -30% | -27% | -27.4% | -27.1% | -25.1% | -22.8% |
| Net Profit | 2.3 | 1.8 | 1.3 | 2.4 | 1.4 | 3.1 | 1.6 | 1.6 | 2.6 | 4.3 |
| EPS in Rs | 1.36 | 0.21 | 0.16 | 0.29 | 0.17 | 0.37 | 0.19 | 0.19 | 0.32 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 44% |
| 3 Years: | 28% |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 71% |
| 3 Years: | 39% |
| 1 Year: | 41% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|